CIEL Healthcare Limited (CHL) is strengthening healthcare provision in Sub-Saharan Africa by developing its network of health facilities. It is the private sector which generally meets the increasing healthcare demand of populations in the region.
CIEL Healthcare Limited (CHL) is a private limited company which owns, operates and manages assets related to the health sector in Mauritius and throughout Sub-Saharan Africa. CHL holds majority shares in International Medical Group (in Uganda), in Hygeia Nigeria Limited (in Nigeria, via a consortium) and in Surgical Centre Limited, the owner of the Fortis-Darné Clinic in Mauritius. CHL’s investments also include the International Bio Analysis Laboratory (LIBA).
The equity investment will contribute to financing the acquisition of health facilities in the region and developing new state-of-the-art medical services in these institutions, which are locally difficult to access (obstetrics, cancer, cardiology, etc.).
This operation will contribute to developing healthcare infrastructure in Sub-Saharan Africa where healthcare provision is structurally in deficit. It should create about a hundred additional beds by 2020, which will allow it to receive 150,000 more patients. More generally, it will contribute to structuring the sector in Sub-Saharan Africa, where the chronic underinvestment by States makes the private sector’s role crucial in addressing strong growth in healthcare demand.